trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from
Ventures Public Company Limited for the first quarter of 2019 We are pleased to submit: 1. Consolidated and Company only Quarterly Review Financial Statements for the first quarter of 2019 (a copy in Thai
Ventures Public Company Limited for the first quarter of 2019 (Revised) We are pleased to submit: 1. Consolidated and Company only Quarterly Review Financial Statements for the first quarter of 2019 (a copy
calculation is based on the Company’s reviewed interim consolidated financial statements for the period of 6 months ended as of 30 June 2018. When combining with three transactions of disposal of asset during
Indorama Ventures Public Company Limited for the first quarter ended March 31, 2021 We are pleased to submit: 1. Consolidated and Company only Quarterly Review of Financial Statements for the first quarter
position for the first quarter of 2018 with those of 2017. This report discusses principal changes in the unreviewed consolidated financial statements. Overall market environment The Thai economy for the
first quarter of 2018 with those of 2017. This report discusses principal changes in the reviewed consolidated financial statements. Overall market environment The Thai economy for the first quarter of
position for the first quarter ended March 31, 2019 with those of 2018. This report discusses principal changes in the unreviewed consolidated financial statements. Overall market environment The Thai
total value of consideration criterion which granted the highest result, referenced from the consolidated audited financial statement of the Company ended March 31, 2019. After the computation of the
of most appropriated methodologies from 2 independent financial advisory firms, the Company recognized the effect from loss of control in these two subsidiaries recorded in the consolidated statements